- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01803230
Creatine Supplementation on Cognition in Children
March 1, 2013 updated by: Bruno Gualano, University of Sao Paulo
Effects of Creatine Supplementation on Cognitive Function in Children
Creatine supplementation may improve cognitive function in elderly and vegetarian individuals.
This study aims to investigate the role of creatine supplementation on cognitive function in healthy children.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sao Paulo, Brazil
- Recruiting
- University of Sao Paulo
-
Contact:
- Carlos Merege
- Phone Number: 5511 30913096
- Email: carlosmeregefilho@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 12 years (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy children
- age between 10 to 12 years of age
Exclusion Criteria:
- cognitive impairment
- vegetarian diet
- use of creatine in the past 6 months
- chronic kidney disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
PLACEBO_COMPARATOR: placebo
placebo (dextrose)
|
|
|
EXPERIMENTAL: creatine
creatine supplementation
|
creatine supplementation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cognitive function
Time Frame: 7 days
|
assessed by a battery of cognitive tests as follows: colors and words attention test, controlled words association test, memory and figures learning, mental flexibility test and inhibitory control, digit span test, and intelligence quotient.
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
tissue creatine content
Time Frame: 7 days
|
as assessed by 1H-MRS.
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2013
Primary Completion (ANTICIPATED)
February 1, 2015
Study Completion (ANTICIPATED)
February 1, 2015
Study Registration Dates
First Submitted
February 27, 2013
First Submitted That Met QC Criteria
March 1, 2013
First Posted (ESTIMATE)
March 4, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
March 4, 2013
Last Update Submitted That Met QC Criteria
March 1, 2013
Last Verified
February 1, 2013
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Creatine in Children
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.